ArticleJournal of translational medicine2025

Efficacy and safety comparison of CAR-T and blinatumomab immunotherapy as bridge-to-transplant strategies in relapsed/refractory B cell acute lymphoblastic leukemia.

Wenyue Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.